Type 2 Diabetes as a Systems-Level Disorder: A Root Driver Model Integrating Metabolic, Nutritional, Hormonal, and Environmental Determinants

Type 2 diabetes mellitus (T2DM) is conventionally managed as a disorder of hyperglycemia. However, large randomized controlled trials—including ACCORD, ADVANCE, and VADT—demonstrate that intensive glycemic control does not consistently reduce macrovascular complications or all-cause mortality. These findings suggest that hyperglycemia is not the sole driver of diabetic pathology and that additional mechanisms contribute to disease progression.From a systems medicine perspective, T2DM can be understood as a systems-level disorder involving oxidative–reductive imbalance, mitochondrial dysfunction, micronutrient depletion, hormonal dysregulation, and environmental influences. However, a unifying framework integrating these upstream determinants into a coherent systems model remains lacking.One potential mechanism is that hyperglycemia may impair cellular uptake of vitamin C via competitive interactions at glucose transporters, leading to a state of functional intracellular deficiency despite normal plasma levels. This phenomenon may contribute to oxidative stress, endothelial dysfunction, and vascular complications.We propose a three-level model of T2DM management: (1) glucose-centric conventional medicine, (2) metabolic regulation via low-carbohydrate and ketogenic diets, and (3) systems-oriented approaches that integrate nutrient status, redox balance, mitochondrial function, hormonal regulation, and environmental factors. While metabolic therapies represent a major advance, they may not fully restore intracellular and systemic biological function. Systems-level approaches may represent an additional layer for investigation in the management of T2DM.